Immune Parameters in The Prognosis and Therapy Monitoring of Cutaneous Melanoma Patients: Experience, Role, and Limitations

Figure 4

Plasma level of IL-6 (a), TNF-α (b), IL-10 (c), IL-12 (d), IL-8 (e), and IL-1β (f) in melanoma patients compared to control.

(a)

(b)

(c)

(d)

(e)

(f)